drugset / Trial / NCT05371262

Influence of Initial Levothyroxine Dose on Neurodevelopmental and Growth Outcomes in Congenital Hypothyroidism

NCT05371262

Phase 4 Completed 72 enrolled Federico II University
RandomizedParallel-groupOpen-labelTreatment

Summary

The primary objective of this study is to evaluate the risk-benefit profile of long-term treatment of two different initials treatment schemes with L-T4 on the neurodevelopmental and auxological outcomes in children with congenital hypothyroidism, diagnosed by neonatal screening in order to find the best dose of initial thyroid hormone replacement to assure the best long-term developmental outcome without any adverse effects on auxological, cardiovascular and skeletal outcomes. The secondary objective of the study is to evaluate the role of other factors that, in addition to the initial L-T4 therapy,can influence long-term neurodevelopmental and auxological outcomes as well as the cardiovascular system and bone metabolism outcomes.

Timeline

Start
2011-05
Primary completion
2018-05
Completion
2018-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Levothyroxine Other / unclassified 10 ug/kg
Comparator Levothyroxine Other / unclassified 12.5 ug/kg
Comparator Levothyroxine Other / unclassified 12.6 ug/kg
Comparator Levothyroxine Other / unclassified 15 ug/kg